DQ heads into June with a striking split: options traders are piling into protection at the most aggressive pace in a year, while short sellers have quietly been covering their positions. The contradiction is the story this week.
The clearest signal comes from the options market. The put/call ratio has climbed to near its 52-week peak — running at 1.98 against a 20-day average of 1.43 — and has held above 1.9 every session since May 21. That's more than a standard deviation above the mean, a sustained wall of defensive positioning that investors have maintained even as the stock ticked 2.6% higher on Tuesday. This isn't a one-day hedge; it's a prolonged shift in sentiment that began around May 20 when the PCR jumped from below 1.4 to above 1.9 essentially overnight.
Short interest tells a contrasting story. Bears have been backing off: the estimated short position dropped 11.3% on the week to roughly 4.2% of the free float, now at 2.8 million shares. That brings short interest to a multi-week low after peaking above 3.2 million shares in mid-May. Borrowing costs remain inexpensive at 0.49% annualised — among the lowest borrowing rates the stock has seen over the past month — and availability is extraordinarily loose at around 1,083% of current short interest, meaning lenders have more than ten shares sitting idle for every one already borrowed. There is no borrow squeeze anywhere in sight, and no sign that new shorts are building in any size. The short score, a composite of all these lending-market signals, has eased from 52.1 on May 25 to 49.1 today, hovering right at the midpoint.
The Street is cautiously constructive in aggregate but the recent analyst moves are mixed enough to warrant scrutiny. The consensus sits at "buy" with a mean price target near $26.77, implying substantial upside from the current $16.80. However, the most recent named action — GLJ Research downgrading to Sell from Buy in early February with a target of $18.13 — underscores that bulls are not unanimous. Earlier upgrades from Citigroup (target $37) and GLJ's own prior upgrade in mid-2025 now look dated against a stock that has dropped roughly 38% in 2026. Goldman Sachs moved to Neutral in April 2025. Given that most of these actions are four months old or more, the consensus read should be treated as directional rather than precise. On valuation, the price-to-book ratio of 0.27 is exceptionally depressed, and the EV/EBITDA of 6.2x is not demanding — but the earnings yield is negative, and the PE is meaningless in loss-making territory. The bull case rests on polysilicon price recovery and projected revenue growth of 15–21% in 2026–27; the bear case centres on a 55%-plus year-on-year decline in Chinese monthly installations and polysilicon prices near CNY 48.5/kg with no near-term floor. One factor score stands out positively: the company ranks in the 98th percentile on EPS surprise, suggesting it has consistently outpaced low expectations.
Ownership is concentrated at the top. The two largest holders — Guangfu Xu and Xiang Xu — together control over 36% of shares, with Xiang Xu's last reported filing showing a 4.77 million-share addition, a move large enough to be material context for any price recovery thesis. Invesco added roughly 594,000 shares in the most recent quarter, and Two Sigma built a new position of nearly 700,000 shares. Morgan Stanley trimmed by 326,000 and Arrowstreet cut by 298,000, so institutional flows are genuinely split. Among named peers, CSIQ surged 12.4% on the day and 8.7% on the week — a sharp contrast to DQ's 6% weekly decline — while JKS fell 1.6% over the same period, suggesting the sector is not moving as a bloc.
The last earnings print on April 29 sent the stock down 12.4% in a single session, with the loss extending to 11.8% over the following five days. The next quarterly event is scheduled for August 3. With put/call positioning near its highest level of the past year and the stock down 12% on the month, the borrow market is open and shorts are retreating — the pressure on DQ right now is coming from the options market, not the short book, and August's polysilicon pricing disclosures will be the next real test of whether that defensive stance was prescient or premature.
See the live data behind this article on ORTEX.
Open DQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
